Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000950170-24-131691

President and CEO sold 50,000 shares at $15.00 ($750,000)

  • President and CEO acquired 50,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BOLNO PAUL · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-25 Exercise or conversion : show line 1 in the form 10b5-1 +50,000 $2.48 $124,000 267,351 D
2024-11-25 Sale : show line 2 in the form 10b5-1 −50,000 $15.00 $750,000 217,351 D
Open-market sales · 50,000 sh · avg $15.00 · $750,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-11-25 Exercise or conversion : show line 3 in the form 10b5-1 Share Option (right to buy) −50,000 47,778 D
Loading xslF345X05/ownership.xml…